Search Results - Alex Soltermann
- Showing 1 - 10 results of 10
-
1
Analysis of the frequency of oncogenic driver mutations and correlation with clinicopathological characteristics in patients with lung adenocarcinoma from Northeastern Switzerland by Alexandra Grosse, Claudia Grosse, Markus Rechsteiner, Alex Soltermann
Published in Diagnostic Pathology (2019-02-01)Get full text
Article -
2
-
3
-
4
Transbronchial Cryobiopsy Compared to Forceps Biopsy for Diagnosis of Acute Cellular Rejection in Lung Transplants: Analysis of 63 Consecutive Procedures by Carolin Steinack, Ariana Gaspert, Fiorenza Gautschi, René Hage, Bart Vrugt, Alex Soltermann, Macé Matthew Schuurmans, Daniel Franzen
Published in Life (2022-06-01)Get full text
Article -
5
Microfluidics-based immunofluorescence for fast staining of ALK in lung adenocarcinoma by Saška Brajkovic, Benjamin Pelz, Maria-Giuseppina Procopio, Anne-Laure Leblond, Grégoire Repond, Ariane Schaub-Clerigué, Diego G Dupouy, Alex Soltermann
Published in Diagnostic Pathology (2018-10-01)Get full text
Article -
6
Low Merlin expression and high Survivin labeling index are indicators for poor prognosis in patients with malignant pleural mesothelioma by Mayura Meerang, Karima Bérard, Martina Friess, Byron K.Y. Bitanihirwe, Alex Soltermann, Bart Vrugt, Emanuela Felley-Bosco, Raphael Bueno, William G. Richards, Burkhardt Seifert, Rolf Stahel, Walter Weder, Isabelle Opitz
Published in Molecular Oncology (2016-10-01)Get full text
Article -
7
Prognostic value of MIB-1 proliferation index in solitary fibrous tumors of the pleura implemented in a new score – a multicenter study by Matthias Diebold, Alex Soltermann, Selma Hottinger, Sarah R. Haile, Lukas Bubendorf, Paul Komminoth, Wolfram Jochum, Rainer Grobholz, Dirk Theegarten, Sabina Berezowska, Kaid Darwiche, Filiz Oezkan, Malcolm Kohler, Daniel P. Franzen
Published in Respiratory Research (2017-12-01)Get full text
Article -
8
HPV and RAD51 as Prognostic Factors for Survival in Inoperable Oral and Oropharyngeal Cancer in Patients Unfit for Chemotherapy Treated with Hyperfractionated Radiotherapy by Zuzana Zděblová Čermáková, Pavel Hurník, David Konvalinka, Jan Štembírek, Tereza Paračková, Kamila Resová, Jakub Cvek, Tomáš Blažek, Lukáš Knybel, Martin Formánek, Mariam Gachechiladze, Markus Joerger, Alex Soltermann, Jozef Škarda, Oldřich Motyka, Jana Janoutová
Published in Medicina (2023-02-01)Get full text
Article -
9
Acquired resistance to anti-PD1 therapy in patients with NSCLC associates with immunosuppressive T cell phenotype by Stefanie Hiltbrunner, Lena Cords, Sabrina Kasser, Sandra N. Freiberger, Susanne Kreutzer, Nora C. Toussaint, Linda Grob, Isabelle Opitz, Michael Messerli, Martin Zoche, Alex Soltermann, Markus Rechsteiner, Maries van den Broek, Bernd Bodenmiller, Alessandra Curioni-Fontecedro
Published in Nature Communications (2023-08-01)Get full text
Article -
10
Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors by Julie George, Vonn Walter, Martin Peifer, Ludmil B. Alexandrov, Danila Seidel, Frauke Leenders, Lukas Maas, Christian Müller, Ilona Dahmen, Tiffany M. Delhomme, Maude Ardin, Noemie Leblay, Graham Byrnes, Ruping Sun, Aurélien De Reynies, Anne McLeer-Florin, Graziella Bosco, Florian Malchers, Roopika Menon, Janine Altmüller, Christian Becker, Peter Nürnberg, Viktor Achter, Ulrich Lang, Peter M. Schneider, Magdalena Bogus, Matthew G. Soloway, Matthew D. Wilkerson, Yupeng Cun, James D. McKay, Denis Moro-Sibilot, Christian G. Brambilla, Sylvie Lantuejoul, Nicolas Lemaitre, Alex Soltermann, Walter Weder, Verena Tischler, Odd Terje Brustugun, Marius Lund-Iversen, Åslaug Helland, Steinar Solberg, Sascha Ansén, Gavin Wright, Benjamin Solomon, Luca Roz, Ugo Pastorino, Iver Petersen, Joachim H. Clement, Jörg Sänger, Jürgen Wolf, Martin Vingron, Thomas Zander, Sven Perner, William D. Travis, Stefan A. Haas, Magali Olivier, Matthieu Foll, Reinhard Büttner, David Neil Hayes, Elisabeth Brambilla, Lynnette Fernandez-Cuesta, Roman K. Thomas
Published in Nature Communications (2018-03-01)Get full text
Article
